China Pharma Holdings (CPHI) Revenue Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.38 Mn | 41.08 Mn | 83,566.00 | -4.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.54% |
| Dec 31, 2025 | -25.13% |
| Sep 30, 2025 | -27.27% |
| Jun 30, 2025 | -14.01% |
| Mar 31, 2025 | -10.86% |
| Dec 31, 2024 | -26.78% |
| Sep 30, 2024 | -17.77% |
| Jun 30, 2024 | -27.38% |
| Mar 31, 2024 | -16.56% |
| Dec 31, 2023 | -9.82% |
| Sep 30, 2023 | -9.09% |
| Jun 30, 2023 | -33.72% |
| Mar 31, 2023 | 3.58% |
| Dec 31, 2022 | -1.41% |
| Sep 30, 2022 | -6.13% |
| Jun 30, 2022 | -14.37% |
| Mar 31, 2022 | -18.19% |
| Dec 31, 2021 | -3.77% |
| Sep 30, 2021 | -4.87% |
| Jun 30, 2021 | -8.70% |